Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continued to decline.

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals will be struck with other ...

On Tuesday, President Donald Trump, health leaders and the CEO of Pfizer announced a new drug pricing deal. The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as ...

The revised bids are the latest unusual twist in the fight between big drugmakers over drug developer Metsera.

On November 4, 2025, Pfizer reported third-quarter earnings showing a year-over-year decline in revenue to US$16.65 billion ...

The Metsera deal is about winning the obesity drugs' market that’s expected to reach US$100 billion by 2030. Read more at ...

Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID product sales.

Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...

President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...

The European Union's drug regulator said on Wednesday that its longer approval process for COVID-19 vaccines was safer, after ...

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.The announcement, ...